Medtronic's diabetes unit MiniMed raises $560 million in US IPO is drawing significant interest across the industry.
MiniMed, the diabetes business of medical ?device maker Medtronic , said on Thursday ?it has raised $560 million in its U.S. initial public offering.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →